Man Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.6M | Sell |
27,447
-14,156
| -34% | -$5.25M | 0.02% | 760 |
|
|
2026
Q1 | $12.2M | Buy |
41,603
+5,706
| +16% | +$1.88M | 0.02% | 724 |
|
|
2025
Q4 | $12.6M | Sell |
35,897
-299
| -0.8% | -$101K | 0.02% | 689 |
|
|
2025
Q3 | $11.7M | Sell |
36,196
-130,304
| -78% | -$40.5M | 0.02% | 718 |
|
|
2025
Q2 | $64.8M | Buy |
166,500
+78,510
| +89% | +$31.6M | 0.12% | 175 |
|
|
2025
Q1 | $38.3M | Buy |
87,990
+24,510
| +39% | +$9.84M | 0.1% | 252 |
|
|
2024
Q4 | $23.4M | Sell |
63,480
-122,922
| -66% | -$51.4M | 0.06% | 371 |
|
|
2024
Q3 | $96.9M | Sell |
186,402
-81,925
| -31% | -$43.8M | 0.25% | 86 |
|
|
2024
Q2 | $145M | Sell |
268,327
-94,879
| -26% | -$50.2M | 0.37% | 43 |
|
|
2024
Q1 | $188M | Sell |
363,206
-268,719
| -43% | -$134M | 0.47% | 28 |
|
|
2023
Q4 | $298M | Buy |
+631,925
| New | +$292M | 0.83% | 11 |
|
|
2023
Q3 | – | Sell |
-513,966
| Closed | -$233M | – | 9 |
|
|
2023
Q2 | $228M | Buy |
+513,966
| New | +$237M | 0.7% | 12 |
|
|
2023
Q1 | – | Sell |
-294,701
| Closed | -$140M | – | 17 |
|
|
2022
Q4 | $151M | Buy |
294,701
+72,849
| +33% | +$37M | 0.54% | 23 |
|
|
2022
Q3 | $101M | Buy |
+221,852
| New | +$106M | 0.47% | 31 |
|
|
2022
Q2 | – | Sell |
-160,364
| Closed | -$79.3M | – | 38 |
|
|
2022
Q1 | $78.8M | Sell |
160,364
-102,935
| -39% | -$47.1M | 0.27% | 78 |
|
|
2021
Q4 | $122M | Buy |
263,299
+80,219
| +44% | +$33.7M | 0.39% | 45 |
|
|
2021
Q3 | $68.3M | Buy |
183,080
+44,949
| +33% | +$17.1M | 0.24% | 90 |
|
|
2021
Q2 | $52.7M | Sell |
138,131
-137,952
| -50% | -$52.7M | 0.19% | 124 |
|
|
2021
Q1 | $99.1M | Buy |
276,083
+47,102
| +21% | +$15.1M | 0.44% | 35 |
|
|
2020
Q4 | $73.5M | Sell |
228,981
-74,782
| -25% | -$22.9M | 0.32% | 57 |
|
|
2020
Q3 | $81.6M | Buy |
303,763
+81,000
| +36% | +$21.8M | 0.32% | 60 |
|
|
2020
Q2 | $58.6M | Buy |
222,763
+177,510
| +392% | +$47.4M | 0.3% | 66 |
|
|
2020
Q1 | $10.3M | Sell |
45,253
-246,307
| -84% | -$67.1M | 0.07% | 284 |
|
|
2019
Q4 | $88.1M | Sell |
291,560
-82,290
| -22% | -$22.6M | 0.29% | 66 |
|
|
2019
Q3 | $89.8M | Buy |
373,850
+165,143
| +79% | +$45.2M | 0.33% | 59 |
|
|
2019
Q2 | $58.9M | Buy |
208,707
+8,590
| +4% | +$2.35M | 0.21% | 95 |
|
|
2019
Q1 | $57.4M | Buy |
200,117
+128,695
| +180% | +$37.2M | 0.22% | 97 |
|
|
2018
Q4 | $18.8M | Sell |
71,422
-32,754
| -31% | -$9.01M | 0.08% | 270 |
|
|
2018
Q3 | $28.6M | Sell |
104,176
-17,154
| -14% | -$4.45M | 0.1% | 208 |
|
|
2018
Q2 | $28.9M | Sell |
121,330
-63,780
| -34% | -$14.8M | 0.12% | 172 |
|
|
2018
Q1 | $40.7M | Buy |
+185,110
| New | +$43.5M | 0.19% | 95 |
|
Other funds holding ELV
Man Group's ELV Position: Q2 2026 in Review
Man Group reduced its Elevance Health (ELV) stake by 34% in Q2 2026, selling an estimated $5.25M and leaving 27,447 shares worth $10.6M. The position accounts for 0.02% of the portfolio, ranked #760.
Man Group first reported a position in ELV in Q1 2018 and has held it in 31 quarters since. The position peaked at $298M in Q4 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Man Group held 27,447 shares of Elevance Health worth $10.6M as of Q2 2026.
- Man Group sold 14,156 Elevance Health shares in Q2 2026, an estimated $5.25M.
- Elevance Health made up 0.02% of Man Group's portfolio in Q2 2026, its #760 holding.
- Man Group first reported a position in Elevance Health in Q1 2018 and has held it in 31 quarters since.
- Man Group's Elevance Health position peaked at $298M in Q4 2023.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.